High levels of Prx 1 and Prx 2 correlated with cisplatin chemoresistance in gastric cancer SNU638 cells [27], in human erythroleukemia K652, in human breast cancer MCF-7 cells [28], and in human ovarian carcinoma SKOV-3 cells [28], as increased levels of this antioxidant inhibited apoptosis. Here, PRRX2 is linked to breast carcinoma.